Clinical Trial Update: A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease. [Phase 3]

View source ↗

Summary

A Phase 3 cardiac safety study of galantamine for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED